Genetic alterations in FRG1 and KMT2C (MLL3) were both significantly associated with a younger age in patients diagnosed with lung adenocarcinoma, especially after correcting for potential predictors, for example, sex and smoking history. Here, KMT2C is linked to lung adenocarcinoma.